Donald School Journal of Ultrasound in Obstetrics and Gynecology

Register      Login

VOLUME 8 , ISSUE 2 ( April-June, 2014 ) > List of Articles

REVIEW ARTICLE

Role of Ultrasound in the Assessment of Female Infertility

Maria Sheikh

Keywords : Female infertility,Transvaginal ultrasound,Color Doppler,Polycystic ovary syndrome,Luteinized unruptured follicle syndrome,Luteal phase defect,Premature ovarian failure,Ovarian endometrioma,Pelvic inflammatory disease,Intrauterine adhesions,Septate uterus,Submucosal fibroid,Endometrial polyp

Citation Information : Sheikh M. Role of Ultrasound in the Assessment of Female Infertility. Donald School J Ultrasound Obstet Gynecol 2014; 8 (2):184-200.

DOI: 10.5005/jp-journals-10009-1354

License: CC BY-NC 4.0

Published Online: 01-06-2014

Copyright Statement:  Copyright © 2014; The Author(s).


Abstract

How to cite this article

Sheikh M, Kupesic Plavsic S. Role of Ultrasound in the Assessment of Female Infertility. Donald School J Ultrasound Obstet Gynecol 2014;8(2):184-200.


PDF Share
  1. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19(1):41.
  2. The role of color Doppler imaging in the diagnosis of polycystic ovary syndrome Am J Obstet Gynecol 1995;172(1):108-113.
  3. Ultrasound assessment of ovarian stroma hypertrophy in hyperandrogenism and ovulation disorders: visual analysis versus computerized quantification. Fertil Steril 1995;64(2):307-312.
  4. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J (Clin Res Ed) 1986;293(6543):355-359.
  5. The prevalence of polycystic ovaries in women with type 2 diabetes mellitus. Clin Endocrinol (Oxf) 2000;52(1):82-86.
  6. The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives. Clin Endocrinol (Oxf) 1990;33(4): 501-510.
  7. Nonclassic 21-hydroxylase deficiency. Fertil Steril 2006;86Suppl 1:S2.
  8. Identification of virilizing adrenal tumors in hirsute women. N Engl J Med 1994;331:968-973.
  9. Glucose intolerance in polycystic ovary syndrome: a position statement of the Androgen Excess Society. J Clin Endocrinol Metab 2007;92(12): 4546-4556.
  10. The pathophysiology of ovarian hyperstimulation syndrome: views and ideas. Hum Reprod 1997;12(6):1129-1137.
  11. The pathogenesis of the ovarian hyperstimulation syndrome. N Engl J Med 2003;349(8):729-732.
  12. Color Doppler and three-dimensional ultrasound imaging in infertility. Color Doppler, 3D and 4D ultrasound in gynecology, infertility and obstetrics. 2nd ed. New Delhi: Jaypee Brothers, 2011, p. 115-130.
  13. The accuracy of transvaginal ultrasonography in the diagnosis of endometrial abnormalities. Obstet Gynecol 1996;87(3):345-349.
  14. Hormonal contraception and risk of endometrial cancer: a systematic review. Endocr Relat Cancer 2010;17(4):R263-271.
  15. Emotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies. Hum Reprod Update 2012;18(6):638-651.
  16. Luteinized unruptured follicle syndrome increased by inactive disease and selective cyclooxygenase 2 inhibitors in women with inflammatory arthropathies. Arthritis Care & Research 2011;63(9):1334-1338.
  17. The assessment of normal and abnormal luteal function by transvaginal color doppler sonography. Eur J Obstet Gynecol and Reprod Bio 1997;72(1):83-87.
  18. Changes in blood-flow impedance of the human corpus luteum throughout the luteal phase and during early pregnancy. Fertil Steril 2008;90(6):2334-2339.
  19. Ovarian stromal blood flow in women with polycystic ovaries: a possible new marker for diagnosis? Hum Reprod 1995;10(8):1992-1996.
  20. Comparison of various therapies for the luteinized unruptured follicle syndrome. Int J Fertil 1992;37(1):33-40.
  21. Luteal phase defect: comparison between Doppler velocimetry, histological and hormonal markers. Ultrasound Obstet Gynaecol 1997;9(2):105-112.
  22. Prognostic significance of morphologic changes of the corpus luteum by transvaginal ultrasound in early pregnancy monitoring. Obstet Gynecol 1995;85(1):37-41.
  23. Color flow pulsed Doppler ultrasound in diagnosing luteal phase defect. Fertil Steril 1995;64:500-504.
  24. A comparison of endometrial and subendometrial vascularity assessed by three-dimensional ultrasonography and power doppler angiography between healthy fertile women and women with unexplained primary recurrent miscarriage. Fertil Steril 2011;95(3): 1127-1129.
  25. Treatment of luteal phase defects in assisted reproduction. Curr Drug Targets 2013;14(8):832-842.
  26. Luteal phase support for in vitro fertilization-embryo-transfer-present and future methods to improve successful implantation. Clin Exp Obstet Gynecol 2012;39(4):422-428.
  27. Clinical practice. Primary ovarian insufficiency. N Engl J Med 2009;360(6):606-614.
  28. Premature ovarian failure. Orphanet J Rare Dis 2006;1(9):1750-1772.
  29. Primary and secondary amenorrhea. In: comprehensive gynecology, 3rd ed, Mosby, St. Louis 1997. p. 1043.
  30. Clinical sonographic pearls. In: Kupesic S, editor. Color Doppler, 3D and 4D ultrasound in gynecology, infertility and obstetrics. 2nd ed. New Delhi: Jaypee Brothers Medical Publishers Pvt Ltd. 2011, p. 270-272.
  31. A prospective evaluation of antral follicle function in women with 46,XX spontaneous primary ovarian insufficiency. Fertil Steril 2010;94(5):1769-1774.
  32. A syndrome characterized by primary ovarian insufficiency and decreased stature: report of 11 cases with a digression on hormonal control of axillary and pubic hair. Am J Med Sci 1942;204:625-648.
  33. Genes and translocations involved in POF. Am J Med Genet 2002;111(3):328-333.
  34. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum Reprod 2006;21(4):952-957.
  35. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet 2005;117(4):376-382.
  36. Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet 2000;66(1):6-15.
  37. Hypergonadotropic hypogonadism in female patients with galactosemia. N Engl J Med 1981;304(17):994-998.
  38. Heterozygosity for the classical galactosemia mutation does not affect ovarian reserve and menopausal age. Reprod Sci 2007;14(8):780-785.
  39. Mutations in eIF4ENIF1 are associated with primary ovarian insufficiency. J Clin Endocrinol Metab 2013;98(9):E1534-1539.
  40. Adrenal antibodies detect asymptomatic auto-immune adrenal insufficiency in young women with spontaneous premature ovarian failure. Hum Reprod 2002;17(8):2096-2100.
  41. Polyglandular autoimmune syndromes. Am J Med Sci 1985;290(2):77-88.
  42. Ovarian antibodies as detected by indirect immunofluorescence are unreliable in the diagnosis of autoimmune premature ovarian failure: a controlled evaluation. BMC Womens Health 2003; 3(1):2.
  43. The case against ovarian biopsy for the diagnosis of premature menopause. Br J Obstet Gynaecol 1994;101(2):96-98.
  44. Gonadal effects of cancer therapy in girls. Cancer 1985;55(10):2364-2372.
  45. Effects of childhood leukemia and chemotherapy on puberty and reproductive function in girls. N Engl J Med 1976;294(21):1143-1146.
  46. Normal pregnancy after curative multiagent chemotherapy for choriocarcinoma with brain metastases. Acta Obstet Gynecol Scand 1991;70(7-8):611-613.
  47. Return of fertility after autologous stem cell transplantation. Fertil Steril 2002;77(2):419-421.
  48. Radiosensitivity of mammalian oocytes with particular reference to the human female. Am J Obstet Gynecol 1971;110(5):746-761.
  49. The association of hysterectomy and menopause: a prospective cohort study. Br J Obstet Gynaecol 2005;112:956-962.
  50. Effect of early menopause on bone mineral density and fractures. Menopause 2007;14(3 pt 2):567-571.
  51. A dose-response study of hormone replacement in young hypogonadal women: effects on intima media thickness and metabolism. Clin Endocrinol (Oxf) 2007;66(4):557-564.
  52. Premature ovarian failure is not premature menopause. Ann N Y Acad Sci 2000;900:393-402.
  53. Cumulative conception and live birth rates after oocyte donation: implications regarding endometrial receptivity. Hum Reprod 1997; 12(4):835-839.
  54. Treatment of autoimmune premature ovarian failure: case report. Human Reproduction 1999;14 (7):1777-1782.
  55. Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure. J Clin Endocrinol Metab 2011;96(12):3864-3872.
  56. The endoscopic localization of endometrial implants in the ovarian chocolate cyst. Fertil Steril 1994;61(6):1034-1038.
  57. Postsurgical ovarian failure after laparoscopic excision of bilateral endometriomas. Am J Obstet Gynecol 2006;195(2):421-425.
  58. Impaired uterine artery flow associated with the presence of ovarian endometrioma: preliminary results of a prospective study. J Ovarian Res 2014; 7(1): 18-21.
  59. Serum CA-125 in preoperative patients at high risk for endometriosis. Obstet Gynecol 2002; 99(3):375-380.
  60. ‘Kissing ovaries’: a sonographic sign of moderate to severe endometriosis. Fertil Steril 2005;83(1): 143-147.
  61. Endovaginal ultrasonography in the diagnosis of adenomyosis uteri: identifying the predictive characteristics. BJOG: Int J Obstet Gynaecol 1995;10(6):471-474.
  62. Excisional surgery versus ablative surgery for ovarian endometriomata. Cochrane Database Syst Rev 2008;16(2):CD004992. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18425908‥
  63. Long-term adjuvant therapy for the prevention of postoperative endometrioma recurrence: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2013;92(1):8-16.
  64. The effect of surgical treatment for endometrioma on in vitro fertilization outcomes: a systematic review and meta-analysis. Fertil Steril 2009;92(1):75-87.
  65. The effect of endometriosis on in vitro fertilisation outcome: a systematic review and meta-analysis. BJOG 2011;120(11): 1308-1320.
  66. Pelvic inflammatory disease. Obstet Gynecol 2010;116(2 Pt 1):419-428.
  67. The value of transvaginal color Doppler in the assessment of pelvic inflammatory disease. J Ultrasound Med Biol 1995;6:733-738.
  68. Loss of nerve fibers in the oviduct isthmus in women with hydrosalpinx. Acta Histochem 2013;115(6):609-615.
  69. Pregnancy rates after invitro fertilization in cases of tubal infertility with and without hydrosalpinx: a meta-analysis of published comparative studies. Hum Reprod 1999;14(5):1243-1249.
  70. Fertil Steril 2008;90(3):S67-68.
  71. Essure® for management of hydrosalpinx prior to in vitro fertilisation: a systematic review and pooled analysis. BJOG 2014;PMID:24393165. Available at: http://www.ncbi.nlm.nih.gov/pubmed/24393165
  72. Hydrosalpinx and infertility: what about conservative surgical management? Eur J Obstet Gynecol Reprod Biol 2011;159(1):122-126.
  73. Etiology of and therapeutic approach to synechia uteri. Eur J Obstet Gynecol Reprod Biol 1996;65(1):109-113.
  74. Predictive value of transvaginal sonography performed before routine diagnostic hysteroscopy for evaluation of infertility. Fertil Steril 2000;73:412.
  75. Asherman syndromeone century later. Fertil Steril 2008;11:759-779.
  76. Diagnostic accuracy of sonohysterography, transvaginal sonography, and hysterosalpingography in patients with uterine cavity diseases. Fertil Steril 2000;73(2):406-411.
  77. J Minim Invas Gynecol 2010;17(1):1-7.
  78. Ultrasound is the optimal choice for guidance in difficult hysteroscopy. Ultrasound Obstet Gynecol 2012;11:715-718.
  79. Preoperative sonographic measurement of endometrial pattern predicts outcome of surgical repair in patients with severe Asherman's syndrome. Fertil Steril 1995;63(2):410-413.
  80. Fertil Steril 1988;49(6):944-955.
  81. The obstetric outcome of in vitro fertilization and embryo transfer in women with congenital uterine malformation. Am J Obstet Gynecol 1996;175(1):85-89.
  82. Complete septate uterus with longitudinal vaginal septum. Fertil Steril 2006;85(3):700-705.
  83. The uterus. In: Clinical Gynecologic Endocrinology and Infertility, Lippincott Williams & Wilkins, Philadelphia 1999. p. 148.
  84. Hysterosalpingography. Fertil Steril 2005; 83(6):1595-1606.
  85. Diagnostic accuracy of sonohysterography, hysterosalpingography and diagnostic hysteroscopy in diagnosis of arcuate, septate and bicornuate uterus. J Obstet Gynaecol Res 2011;37(3):178-186.
  86. Two-and three-dimensional ultrasonography and sonohysterography versus hysteroscopy with laparoscopy in the differential diagnosis of septate, bicornuate, and arcuate uteri. J Minim Invasive Gynecol 2013;20(1):90-99.
  87. Clinical value of three-dimensional transvaginal sonography in diagnosis of septate uterus and prediction of adverse pregnancy outcome. Zhonghua Fu Chan Ke Za Zhi 2013;48(7):499-503.
  88. Hysteroscopic metroplasty for septate uterus. Obstet Gynecol Clin North Am 1995;22(3):473-489.
  89. Uterine myomas: management. Fertil Steril 2007;88(2):255-271.
  90. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril 2009;91(4):1215-1223.
  91. Comparison of hysterosonography and hysteroscopy for diagnosing perimenopausal bleeding. Clin Exp Obstet Gynecol 2013; 40(2):246-249.
  92. Color Doppler sonohysterography of endometrial polyps and submucosal fibroids. J Ultrasound Med 2003;22(6):601-614.
  93. The assessment of benign uterine tumor vascularization by transvaginal color Doppler. Ultrasound Med Biol 1992;18:645-649.
  94. The effect of uterine fibroids on embryo implantation. Semin Reprod Med 2007;25(6):483-489.
  95. Treatment of uterine fibroids: is surgery obsolete? N Engl J Med 2007;356(4):411-413.
  96. Outcomes from assisted reproductive technology. Obstet Gynecol 2006;107(1):183-200.
  97. Treatment of endometrial polyps: a systematic review. Acta Obstet Gynecol Scand 2010;89(8):992-1002.
  98. Diagnosis and management of endometrial polyps: a critical review of the literature. J Minim Invasive Gynecol 2011;18(5):569-581.
  99. Likelihood ratio of sonohysterographic findings for discriminating endometrial polyps from submucosal fibroids. J Ultrasound Med 2014;33(1): 22-25.
  100. Recurrent implantation failure: definition and management. Reprod Biomed Online 2014;28(1):14-38.
  101. Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities. Cochrane Database Syst Rev 2013;1:CD009461. Available at: http://www.ncbi.nlm.nih.gov/pubmed/23440838.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.